Skip to main content
Top
Published in: Diabetologia 5/2015

01-05-2015 | Short Communication

Testing the fuel-mediated hypothesis: maternal insulin resistance and glucose mediate the association between maternal and neonatal adiposity, the Healthy Start study

Authors: Allison L. B. Shapiro, Sarah J. Schmiege, John T. Brinton, Deborah Glueck, Tessa L. Crume, Jacob E. Friedman, Dana Dabelea

Published in: Diabetologia | Issue 5/2015

Login to get access

Abstract

Aims/hypothesis

In women who are overweight or obese before or during pregnancy there is an associated risk of increased fetal growth and higher birthweight. The metabolic phenotype of the overweight/obese pregnant woman, characterised by higher than normal insulin resistance (IR) and increased circulating fuels, suggests a mechanism resulting in fetal overnutrition and subsequent increased adiposity. We tested the fuel-mediated hypothesis in an observational pre-birth cohort of 951 mother–offspring pairs, the Healthy Start study.

Methods

We conducted a path analysis to estimate the simultaneous effects of maternal IR and maternal fuels (fasting glucose, triacylglycerol [TG] and NEFA levels) in late pregnancy in mediating the relationship between maternal pre-pregnancy BMI and neonatal adiposity (per cent fat mass [%FM]).

Results

The total effect of maternal BMI on neonatal %FM was significant (total effect 0.16, 95% CI 0.08, 0.22, p < 0.001). The mediated path including maternal IR and glucose levels together accounted for 21% (p < 0.01) of the total effect of maternal BMI on neonatal %FM while the mediating effects of all other fuels were non-significant.

Conclusions/interpretation

Using a novel application of path analysis our data implicate maternal IR and glucose levels as important mediators of the association between maternal and infant adiposity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sewell MF, Huston-Presley L, Super DM, Catalano P (2006) Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 195:1100–1103CrossRefPubMed Sewell MF, Huston-Presley L, Super DM, Catalano P (2006) Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 195:1100–1103CrossRefPubMed
2.
go back to reference Hull HR, Dinger MK, Knehans AW, Thompson DM, Fields DA (2008) Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol 198:416.e1–e6CrossRef Hull HR, Dinger MK, Knehans AW, Thompson DM, Fields DA (2008) Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol 198:416.e1–e6CrossRef
3.
go back to reference Boney CM, Verma A, Tucker R, Vohr BR (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115:e290–e296CrossRefPubMed Boney CM, Verma A, Tucker R, Vohr BR (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115:e290–e296CrossRefPubMed
4.
go back to reference Hochner H, Friedlander Y, Calderon-Margalit R et al (2012) Associations of maternal prepregnancy body mass index and gestational weight gain with adult offspring cardiometabolic risk factors: the Jerusalem Perinatal Family Follow-up Study. Circulation 125:1381–1389CrossRefPubMedCentralPubMed Hochner H, Friedlander Y, Calderon-Margalit R et al (2012) Associations of maternal prepregnancy body mass index and gestational weight gain with adult offspring cardiometabolic risk factors: the Jerusalem Perinatal Family Follow-up Study. Circulation 125:1381–1389CrossRefPubMedCentralPubMed
5.
go back to reference Harmon KA, Gerard L, Jensen DR et al (2011) Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth. Diabetes Care 34:2198–2204CrossRefPubMedCentralPubMed Harmon KA, Gerard L, Jensen DR et al (2011) Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth. Diabetes Care 34:2198–2204CrossRefPubMedCentralPubMed
6.
go back to reference Endo S, Maeda K, Suto M et al (2006) Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus. Gynecol Endocrinol 22:343–349CrossRefPubMed Endo S, Maeda K, Suto M et al (2006) Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus. Gynecol Endocrinol 22:343–349CrossRefPubMed
7.
go back to reference Lowe LP, Metzger BE, Dyer AR et al (2012) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 35:574–580CrossRefPubMedCentralPubMed Lowe LP, Metzger BE, Dyer AR et al (2012) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 35:574–580CrossRefPubMedCentralPubMed
8.
go back to reference Aris IM, Soh SE, Tint MT et al (2014) Effect of maternal glycemia on neonatal adiposity in a multiethnic Asian birth cohort. J Clin Endocrinol Metab 99:240–247CrossRefPubMed Aris IM, Soh SE, Tint MT et al (2014) Effect of maternal glycemia on neonatal adiposity in a multiethnic Asian birth cohort. J Clin Endocrinol Metab 99:240–247CrossRefPubMed
9.
go back to reference Friis CM, Qvigstad E, Paasche Roland MC et al (2013) Newborn body fat: associations with maternal metabolic state and placental size. PLoS One 8:e57467CrossRefPubMedCentralPubMed Friis CM, Qvigstad E, Paasche Roland MC et al (2013) Newborn body fat: associations with maternal metabolic state and placental size. PLoS One 8:e57467CrossRefPubMedCentralPubMed
10.
go back to reference Visiedo F, Bugatto F, Sánchez V, Cózar-Castellano I, Bartha JL, Perdomo G (2013) High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta. Am J Physiol Endocrinol Metab 305:E205–E212CrossRefPubMed Visiedo F, Bugatto F, Sánchez V, Cózar-Castellano I, Bartha JL, Perdomo G (2013) High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta. Am J Physiol Endocrinol Metab 305:E205–E212CrossRefPubMed
Metadata
Title
Testing the fuel-mediated hypothesis: maternal insulin resistance and glucose mediate the association between maternal and neonatal adiposity, the Healthy Start study
Authors
Allison L. B. Shapiro
Sarah J. Schmiege
John T. Brinton
Deborah Glueck
Tessa L. Crume
Jacob E. Friedman
Dana Dabelea
Publication date
01-05-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 5/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3505-z

Other articles of this Issue 5/2015

Diabetologia 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.